The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1323
ISSUE 1323
October 19, 2009
Issue 1323
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Generic Drugs Revisited
October 19, 2009 (Issue: 1323)
The equivalence of generic drugs to their brand-name precursors continues to be controversial. The last Medical Letter review of this subject (2002) concluded that well-documented therapeutic inequivalence between brand-name and FDA-approved generic...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.